Article
B + L to purchase Technolas
Bausch + Lomb (B + L), and Technolas Perfect Vision GmbH (TPV), an ophthalmology laser company, have entered into a definitive agreement that provides B + L the option of purchasing all outstanding and unowned TPV shares for a total company value of up to 450 million Euros. The value is based on the achievement of certain milestones and earnouts by TPV.
Rochester, NY, and Munich, Germany-Bausch + Lomb (B + L), and Technolas Perfect Vision GmbH (TPV), an ophthalmology laser company, have entered into a definitive agreement that provides B + L the option of purchasing all outstanding and unowned TPV shares for a total company value of up to €450 million. The value is based on the achievement of certain milestones and earnouts by TPV.
TPV was established in 2009 through a joint venture between B + L and 20/10 Perfect Vision AG to develop and sell advanced refractive and cataract technologies.
“We have tremendous confidence in TPV’s femtosecond laser technology and the company’s ability to deliver a platform that will meet the needs of doctors and patients well into the future,” said Brent Saunders, chief executive officer of B + L.
As previously announced, B + L and TPV will jointly promote and advance femtosecond laser platforms worldwide.
Newsletter
Don’t miss out—get Ophthalmology Times updates on the latest clinical advancements and expert interviews, straight to your inbox.
